
German pharma firm Merck KGaA has agreed to hand over its CAR-T therapy business to US company Intrexon in a …

Merck Serono has announced a significant deal with Intrexon to develop and bring new cancer treatments to market. The German …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

